News & Perspective

Oct 29, 2009

Oct 29, 2009

Statins may help patients with severe seasonal flu

(CIDRAP News) – Commonly available drugs that are sold in lower-cost generic versions improve the survival of patients hospitalized for seasonal influenza, researchers reported today, raising the possibility of a widely available treatment that could be used in a severe flu pandemic if other drugs are in short supply.

Oct 26, 2009

Oct 26, 2009

Emergency authorization for peramivir draws fast response

(CIDRAP News) – Requests to use the intravenous (IV) antiviral drug peramivir in hospitalized H1N1 flu patients came quickly after the government issued an emergency use authorization (EUA) Oct 23, a Centers for Disease Control and Prevention (CDC) official said today.

Apr 30, 2009

Apr 30, 2009

Flu experts counter Biden's travel advice

(CIDRAP News) – Vice President Joe Biden today told Matt Lauer on NBC's "Today" show that he has advised his family not to fly on airlines or ride subways to avoid exposure to the swine flu virus, a message that goes well beyond the government's current travel advice for Americans to avoid nonessential trips to Mexico.

Mar 02, 2009

Mar 02, 2009

H1N1 viruses gain Tamiflu resistance without losing fitness

(CIDRAP News) – Studies published today confirm that influenza A/H1N1 viruses have become widely resistant to oseltamivir (Tamiflu), the leading flu drug, without losing their ability to make people sick—thereby underlining the need for new antiviral drugs.

Feb 03, 2009

Feb 03, 2009

Experts weigh new H5N1 vaccine strategies

(CIDRAP News) – At an Infectious Diseases Society of America (IDSA) symposium in Washington, DC, today on seasonal and pandemic influenza, a group of experts fielded questions from reporters on some of the new trends and emerging issues, including prepandemic strategies for H5N1 avian influenza vaccines, now that some countries are stockpiling them.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»